Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.

This study provides further support that empirical criteria aid in examining the progression of clinical characteristics associated with MCI. Further, it helps to identify which MCI subtypes may be at higher risk for NPS progression.